Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer

被引：0
|
作者：
P L Nguyen
N E Martin
V Choeurng
B Palmer-Aronsten
T Kolisnik
C J Beard
P F Orio
M D Nezolosky
Y-W Chen
H Shin
E Davicioni
F Y Feng
机构：
[1] Dana-Farber/Brigham and Women’s Cancer Center and Harvard Medical School,Department of Radiation Oncology
[2] GenomeDx Biosciences,Department of Radiation Oncology
[3] University of California at San Francisco,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2017年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：186 / 192
页数：6
相关论文
共 50 条
  • [1] Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer
    Nguyen, P. L.
    Martin, N. E.
    Choeurng, V.
    Palmer-Aronsten, B.
    Kolisnik, T.
    Beard, C. J.
    Orio, P. F.
    Nezolosky, M. D.
    Chen, Y-W
    Shin, H.
    Davicioni, E.
    Feng, F. Y.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (02) : 186 - 192
  • [2] The Use of a Biopsy-Based Genomic Classifier to Predict the Risk of Distant Metastasis After Definitive Radiation and Short-Course Androgen Deprivation Therapy for Intermediate- and High-Risk Prostate Cancer
    Nguyen, P. L.
    Martin, N. E.
    Palmer-Aronsten, B. J.
    Choeurng, V.
    Kolisnik, T.
    Beard, C. J.
    Nezolosky, M. D.
    Chen, Y. W.
    Shin, H.
    Davicioni, E.
    Feng, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S113 - S114
  • [3] A biopsy-based genomic classifier to predict biochemical failure after definitive radiation without hormone therapy in a prospective cohort of intermediate risk prostate cancer.
    Chua, Melvin
    Murgic, Jure
    Hosni, Ali
    Salcedo, Adriana
    Kamel-Reid, Suzanne
    Berlin, Alejandro
    Pintile, Melania
    Fraser, Michael
    Van Der Kwast, Theodorus
    Boutros, Paul Christopher
    Bristow, Robert G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [4] Percentage of positive biopsy cores to predict distant metastasis of prostate cancer after definitive radiation therapy
    Huang, J.
    Kestin, L. L.
    Vicini, F. A.
    Williams, S. G.
    Ye, H.
    McGrath, S. D.
    Ghilezan, M.
    Martinez, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [5] A Biopsy Based Genomic Classifier Predicts Biochemical Failure and Metastasis after Definitive Radiation without Hormone Therapy in a Prospective Cohort of Intermediate-Risk Prostate Cancer
    Chua, M. L. K.
    Bristow, R. G.
    Murgic, J.
    Abdalaty, A. Hosni
    Salcedo, A.
    Kamel-Reid, S.
    Fraser, M.
    Zhang, J.
    Wang, Q.
    Ch'ng, C.
    Deheshi, S.
    Davicioni, E.
    Van der Kwast, T.
    Boutros, P.
    Berlin, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S99 - S99
  • [6] Intermediate versus short-course hormone therapy and mortality in men with high-risk prostate cancer treated with radiation therapy
    Nanda, Akash
    Chen, Ming-Hui
    Moran, Brian Joseph
    Braccioforte, Michelle H.
    D'Amico, Anthony Victor
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [7] Validation of a Genomic Classifier for Predicting Metastasis Following Postoperative Radiation Therapy in High-Risk Prostate Cancer
    Den, R. B.
    Karnes, R.
    Feng, F. Y.
    Showalter, T. N.
    Mishra, M. V.
    Trabulsi, E. J.
    Lallas, C. D.
    Gomella, L. G.
    Birbe, R.
    McCue, P.
    Yousefi, K.
    Ghadessi, M.
    Davicioni, E.
    Kelly, W.
    Knudsen, K. E.
    Dicker, A. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S157 - S157
  • [8] Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens
    Nguyen, Paul L.
    Haddad, Zaid
    Ross, Ashley E.
    Martin, Neil E.
    Deheshi, Samineh
    Lam, Lucia L. C.
    Chelliserry, Jijumon
    Tosoian, Jeffrey J.
    Lotan, Tamara L.
    Spratt, Daniel E.
    Stoyanova, Radka S.
    Punnen, Sanoj
    Ong, Kaye
    Buerki, Christine
    Aranes, Maria
    Kolisnik, Tyler
    Margrave, Jennifer
    Yousefi, Kasra
    Choeurng, Voleak
    Davicioni, Elai
    Trock, Bruce J.
    Kane, Christopher J.
    Pollack, Alan
    Davis, John W.
    Feng, Felix Y.
    Klein, Eric A.
    EUROPEAN UROLOGY, 2017, 72 (05) : 845 - 852
  • [9] Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer
    Tsai, Henry K.
    Chen, Ming-Hui
    McLeod, David G.
    Carroll, Peter R.
    Richie, Jerome P.
    D'Amico, Anthony V.
    CANCER, 2006, 107 (11) : 2597 - 2603
  • [10] Is the short course ADT with 76Gy IGRT appropriate for intermediate and high risk prostate cancer?
    Hatano, K.
    Ueda, T.
    Kobayashi, M.
    Fukasawa, S.
    Komaru, A.
    Hara, R.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S662 - S663
12345